Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase

Biochimica et Biophysica Acta - General Subjects

Volumn 1861, Issue 11, 2017, Pages 2843-2851

  Platella, Chiara ^a   Guida, Serena ^b   Bonmassar, Laura ^c   Aquino, Angelo ^d   Bonmassar, Enzo ^b   Ravagnan, Giampiero ^b   Montesarchio, Daniela ^a   Roviello, Giovanni N ^e   Musumeci, Domenica ^a,e   Fuggetta, Maria Pia ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e CNR   (Italy)

Author keywords

G quadruplex DNA; hTERT; Melanoma cells; Resveratrol; Telomerase activity; Telomeres

Indexed keywords

COPPER ION; DOUBLE STRANDED DNA; GUANINE QUADRUPLEX; RESVERATROL; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; ANTINEOPLASTIC AGENT; COPPER; STILBENE DERIVATIVE; TERT PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BIOASSAY; BIOPHYSICS; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL VIABILITY; CIRCULAR DICHROISM; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA SEQUENCE; DRUG CYTOTOXICITY; DRUG DNA INTERACTION; DRUG MECHANISM; ENZYME ACTIVITY; FLUORESCENCE SPECTROSCOPY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOICHIOMETRY; ULTRAVIOLET RADIATION; CELL PROLIFERATION; CHEMISTRY; CONFORMATION; DRUG EFFECTS; GENETICS; MELANOMA; PATHOLOGY; SPECTROFLUOROMETRY; SPECTROSCOPY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOPHYSICAL PHENOMENA; CELL LINE, TUMOR; CELL PROLIFERATION; CIRCULAR DICHROISM; COPPER; G-QUADRUPLEXES; HUMANS; MELANOMA; NUCLEIC ACID CONFORMATION; SPECTROMETRY, FLUORESCENCE; SPECTRUM ANALYSIS; STILBENES; TELOMERASE;

EID: 85027223716     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2017.08.001     Document Type: Article

References (52)

1. Mehta, R.G., Pezzuto, J.M., Discovery of cancer preventive agents from natural products: from plants to prevention. Curr. Oncol. Rep. 4 (2002), 478–486.
2. Rivière, C., Pawlus, A.D., Mérillon, J.M., Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae. Nat. Prod. Rep. 29 (2012), 1317–1333.
3. Kala, R., Tollefsbol, T.O., Li, Y., Potential of resveratrol in inhibiting cancer and slowing aging. J. Nutr. Food Sci., S5, 2012, 001.
4. Baur, J.A., Sinclair, D.A., Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006), 493–506.
5. Frendo-Cumbo, S., MacPherson, R.E., Wright, D.C., Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance. Physiol. Rep., 4, 2016, e12877.
6. Erdogan, C.S., Vang, O., Challenges in analyzing the biological effects of resveratrol. Nutrients, 8, 2016, E353.
7. Falchetti, R., Fuggetta, M.P., Lanzilli, G., Tricarico, M., Ravagnan, G., Effects of resveratrol on human immune cell function. Life Sci. 70 (2001), 81–96.
8. Lanzilli, G., Cottarelli, A., Nicotera, G., Guida, S., Ravagnan, G., Fuggetta, M.P., Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 35 (2012), 240–248.
9. Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S., Takada, Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004), 2783–2840.
10. Sirerol, J.A., Rodríguez, M.L., Mena, S., Asensi, M.A., Estrela, J.M., Ortega, A.L., Role of natural stilbenes in the prevention of cancer. Oxidative Med. Cell. Longev., 2016, 2016, 3128951.
11. Pavan, A.R., Silva, G.D., Jornada, D.H., Chiba, D.E., Fernandes, G.F., Man Chin, C. et al., Unraveling the anticancer effect of curcumin and resveratrol. Nutrients, 8, 2016, E628.
12. Wu, H., Wang, Y., Wu, C., Yang, P., Li, H., Li, Z., Resveratrol induces cancer cell apoptosis through MiR-326/PKM2-mediated ER stress and mitochondrial fission. J. Agric. Food Chem. 64 (2016), 9356–9367.
13. Thiel, G., Rössler, O.G., Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol. Res. 117 (2017), 166–176.
14. Schmidt, H.H., Stocker, R., Vollbracht, C., Paulsen, G., Riley, D., Daiber, A., Antioxidants in translational medicine. Antioxid. Redox Signal. 23 (2015), 1130–1143.
15. Wu, Z., Liu, B., E, C., Liu, J., Zhang, Q., Liu, J. et al., Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis. Mol. Med. Rep. 11 (2015), 400–404.
16. Fang, Y., Bradley, M.J., Cook, K.M., Herrick, E.J., Nicholl, M.B., A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J. Surg. Res. 183 (2013), 645–653.
17. Fuggetta, M.P., D'Atri, S., Lanzilli, G., Tricarico, M., Cannavo, E., Zambruno, G. et al., In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res. 14 (2004), 189–196.
18. Martínez, P., Blasco, M.A., Telomere-driven diseases and telomere-targeting therapies. J. Cell Biol. 216 (2017), 875–887.
19. Gomez, D.E., Armando, R.G., Farina, H.G., Menna, P.L., Cerrudo, C.S., Ghiringhelli, P.D., Telomere structure and telomerase in health and disease (review). Int. J. Oncol. 41 (2012), 1561–1569.
20. Ivancich, M., Schrank, Z., Wojdyla, L., Leviskas, B., Kuckovic, A., Sanjali, A. et al., Treating cancer by targeting telomeres and telomerase. Antioxidants (Basel), 6, 2017, E15.
21. Xia, L., Wang, X.X., Hu, X.S., Guo, X.G., Shang, Y.P., Chen, H.J., Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br. J. Pharmacol. 155 (2008), 387–394.
22. Wang, X.B., Zhu, L., Huang, J., Yin, Y.G., Kong, X.Q., Rong, Q.F. et al., Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells. Chin. Med. J. 124 (2011), 4310–4315.
23. Zhai, X.X., Ding, J.C., Tang, Z.M., Li, J.G., Li, Y.C., Yan, Y.H. et al., Effects of resveratrol on the proliferation, apoptosis and telomerase ability of human A431 epidermoid carcinoma cells. Oncol. Lett. 11 (2016), 3015–3018.
24. Lanzilli, G., Fuggetta, M.P., Tricarico, M., Cottarelli, A., Serafino, A., Falchetti, R.R. et al., Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int. J. Oncol. 28 (2006), 641–648.
25. Fuggetta, M.P., Lanzilli, G., Tricarico, M., Cottarelli, A., Falchetti, R., Ravagnan, G. et al., Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. J. Exp. Clin. Cancer Res. 25 (2006), 189–193.
26. Khosravi-Maharlooei, M., Jaberipour, M., Hosseini Tashnizi, A., Attar, A., Amirmoezi, F., Habibagahi, M., Expression pattern of alternative splicing variants of human telomerase reverse transcriptase (hTERT) in cancer cell lines was not associated with the origin of the cells. Int. J. Mol. Cell. Med. 4 (2015), 110–119.
27. Rhodes, D., Lipps, H.J., G-quadruplexes and their regulatory roles in biology. Nucleic Acids Res. 43 (2015), 8627–8637.
28. Neidle, S., Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J. 277 (2010), 1118–1125.
29. Micheli, E., Martufi, M., Cacchione, S., De Santis, P., Savino, M., Self-organization of G-quadruplex structures in the hTERT core promoter stabilized by polyaminic side chain perylene derivatives. Biophys. Chem. 153 (2010), 43–53.
30. Chaires, J.B., Trent, J.O., Gray, R.D., Dean, W.L., Buscaglia, R., Thomas, S.D. et al., An improved model for the hTERT promoter quadruplex. PLoS One, 9, 2014, e115580.
31. Pagano, B., Amato, J., Iaccarino, N., Cingolani, C., Zizza, P., Biroccio, A. et al., Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules. ChemMedChem 10 (2015), 640–649.
32. Cantor, C.R., Schimmel, P.R., Biophysical Chemistry. Vol. 3, 1980, W.H. Freeman, San Francisco, CA.
33. N'soukpoé-Kossi, C.N., Bourassa, P., Mandeville, J.S., Bekale, L., Tajmir-Riahi, H.A., Structural modeling for DNA binding to antioxidants resveratrol, genistein and curcumin. J. Photochem. Photobiol. B 151 (2015), 69–75.
34. Pagano, B., Virno, A., Mattia, C.A., Giancola, C., Targeting DNA quadruplexes with distamycin A and its derivatives: an ITC and NMR study. Biochimie 90 (2008), 1224–1232.
35. Masiero, S., Trotta, R., Pieraccini, S., De Tito, S., Perone, R., Randazzo, A. et al., A non-empirical chromophoric interpretation of CD spectra of DNA G-quadruplex structures. Org. Biomol. Chem. 8 (2010), 2683–2692.
36. Petraccone, L., Spink, C., Trent, J.O., Garbett, N.C., Mekmaysy, C.S., Giancola, C. et al., Structure and stability of higher-order human telomeric quadruplexes. J. Am. Chem. Soc. 133 (2011), 20951–20961.
37. Kypr, J., Kejnovská, I., Renčiuk, D., Vorlíčková, M., Circular dichroism and conformational polymorphism of DNA. Nucleic Acids Res. 37 (2009), 1713–1725.
38. Musumeci, D., Amato, J., Zizza, P., Platella, C., Cosconati, S., Cingolani, C. et al., Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes. Biochim. Biophys. Acta 1861 (2017), 1427–1445.
39. Tanaka, A., Fukuoka, Y., Morimoto, Y., Honjo, T., Koda, D., Goto, M. et al., Cancer cell death induced by the intracellular self-assembly of an enzyme-responsive supramolecular gelator. J. Am. Chem. Soc. 137 (2015), 770–775.
40. Musumeci, D., Roviello, G.N., Rigione, G., Capasso, D., Di Gaetano, S., Riccardi, C. et al., Benzodifuran derivatives as potential antiproliferative agents: possible correlation between the bioactivity and their aggregation properties. ChemPlusChem 82 (2017), 251–260.
41. Coppola, C., Saggiomo, V., Di Fabio, G., De Napoli, L., Montesarchio, D., Novel amphiphilic cyclic oligosaccharides: synthesis and self-aggregation properties. J. Organomet. Chem. 72 (2007), 9679–9689.
42. Brewer, G.J., Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov. Today 10 (2005), 1103–1109.
43. Goodman, V.L., Brewer, G.J., Merajver, S.D., Copper deficiency as an anti-cancer strategy. Endocr. Relat. Cancer 11 (2004), 255–263.
44. Apelgot, S., Coppey, J., Fromentin, A., Guille, E., Poupon, M.F., Roussel, A., Altered distribution of copper (64Cu) in tumor bearing mice and rats. Anticancer Res. 6 (1986), 159–164.
45. Zuo, X.L., Chen, J.M., Zhou, X., Li, X.Z., Mei, G.Y., Levels of selenium, zinc, copper and antioxidant enzyme activity in patients with leukemia. Biol. Trace Elem. Res. 114 (2006), 41–54.
46. Pan, Q., Kleer, C.G., van Golen, K.L., Irani, J., Bottema, K.M., Bias, C. et al., Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 62 (2002), 4854–4859.
47. Goodman, V.L., Brewer, G.J., Merajver, S.D., Control of copper status for cancer therapy. Curr. Cancer Drug Targets 5 (2005), 543–549.
48. Rai, G., Mishra, S., Suman, S., Shukla, Y., Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: a mechanistic insight. Phytomedicine 23 (2016), 233–242.
49. Amato, J., Morigi, R., Pagano, B., Pagano, A., Ohnmacht, S., De Magis, A. et al., Toward the development of specific G-quadruplex binders: synthesis, biophysical, and biological studies of new hydrazone derivatives. J. Med. Chem. 59 (2016), 5706–5720.
50. Musumeci, D., Amato, J., Randazzo, A., Novellino, E., Giancola, C., Montesarchio, D. et al., G-quadruplex on oligo affinity support (G4-OAS): an easy affinity chromatography-based assay for the screening of G-quadruplex ligands. Anal. Chem. 86 (2014), 4126–4130.
51. Milelli, A., Tumiatti, V., Micco, M., Rosini, M., Zuccari, G., Raffaghello, L. et al., Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents. Eur. J. Med. Chem. 57 (2012), 417–428.
52. Roviello, G.N., Crescenzo, C., Capasso, D., Di Gaetano, S., Franco, S., Bucci, E.M. et al., Synthesis of a novel Fmoc-protected nucleoaminoacid for the solid phase assembly of 4-piperidyl glycine/L-arginine-containing nucleopeptides and preliminary RNA interaction studies. Amino Acids 39 (2010), 795–800.